BlueChoice HealthPlan works with our pharmacy benefit manager to continually evaluate our prescription drug formularies and drug management programs to ensure effective management of quality and costs.

Based on recent reviews, BlueChoice® will make minimal changes to our formulary effective Sept. 1, 2017. This information applies to the Blue OptionSM and BusinessADVANTAGE lines of business.

Excluded DrugsBrand Vytorin will no longer be covered, effective Sept. 1, 2017.

The following drugs will no longer be covered, effective Sept. 1, 2017. However, BlueChoice will continue to pay claims for them until Oct. 1, 2017, to make this transition easier for members impacted by these changes. After that date, members will have to pay the full cost to keep using them.

Brand AplenzinTaclonex suspension

Brand EpiPen/EpiPen Jr

Quantity Limits or Step Therapy Requirements

Doxepin topical will have a new quantity limit and step therapy requirement beginning Sept. 1, 2017.

Livalo will have a new step therapy requirement beginning Sept. 1, 2017.

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}
>